Keyphrases
Tumor
100%
Double-strand Breaks
60%
Cellular Response
50%
DNA Double-strand Breaks
46%
DNA Damage Response
40%
HPV16
40%
DNA Damage
39%
DNA Double-strand Break Repair
37%
Point mutation
36%
Breast Cancer Susceptibility Gene 1 (BRCA1)
34%
Copy number Variation
34%
Cas9 Protein
34%
Meningioma
34%
Pancreatic Cancer
34%
Grade II Meningioma
34%
Rad17
34%
Chemoradiation
34%
Protospacer Adjacent Motif
34%
Selective Targeting
34%
Human Monocytes
34%
MRE11-RAD50-NBS1 Complex
34%
Transcript Expression
34%
Cervical Cancer
34%
Dendritic Cells
34%
Anticancer Immune Response
34%
Monocytes
34%
Response to Chemotherapy
34%
Tumor Response
34%
CRISPR-Cas
34%
E7 Gene
34%
Response to Radiation
34%
Chromatin Binding
34%
RNA-guided Endonucleases
34%
High-risk Human Papillomavirus (HR-HPV)
34%
E6 Gene
34%
Grade III Meningioma
34%
Cervical Carcinoma Cells
34%
ATR Pathway
34%
Excessive Apoptosis
34%
Somatic mutation
34%
Nucleolin
34%
Molecular Glioblastoma
34%
Macrophages
34%
Temozolomide
34%
Transperineal
34%
Transperineal Prostate Biopsy
34%
Hydrogel Spacer
34%
Radiation Therapy for Prostate Cancer
34%
Rectal Wall
34%
Infiltration
34%
Biochemistry, Genetics and Molecular Biology
RNA
68%
P53
58%
Progression Free Survival
51%
Overall Survival
45%
Transcription
42%
Human Papillomavirus Type 16
42%
BRCA1
41%
Point Mutation
40%
DNA Damage Response
38%
RNF8
37%
Genetics
37%
RAD17
34%
Epidermal Growth Factor Receptor
34%
Radiosensitivity
34%
Nucleosome
34%
Oxidative Stress
34%
Copy-Number Variation
34%
Endonuclease
34%
Apoptosis
34%
DNA Replication
34%
Protospacer Adjacent Motif
34%
Cyclophosphamide
34%
Isocitrate Dehydrogenase
34%
CRISPR
34%
Wart Virus
34%
Somatic Mutation
34%
Epigenetics
34%
Enzyme
34%
Monocyte
34%
Nucleolin
34%
Bromodomain
34%
CRISPR/Cas9
34%
Cell Death
29%
Drug Megadose
25%
Low Drug Dose
25%
Caspase
25%
Histone
23%
Upregulation
22%
MDC1
22%
Macrophage
21%
Dendritic Cell
21%
Homologous Recombination
20%
DNA Damage
20%
Chromatin Remodeling
19%
Positive Feedback
17%
Whole Genome Sequencing
17%
Cas9
17%
Recombination Repair
17%
Cell Cycle Arrest
16%
Lysine
13%
Medicine and Dentistry
Radiation Therapy
86%
Neoplasm
85%
Clustered Regularly Interspaced Short Palindromic Repeat
68%
Malignant Neoplasm
59%
Cas9
42%
Cervical Cancer
38%
Isocitrate Dehydrogenase
34%
Pancreas Cancer
34%
Endonuclease
34%
DNA Damage Response
34%
Epidermal Growth Factor Receptor
34%
Medulloblastoma
34%
Somatic Mutation
34%
Wart Virus
34%
Chemoradiotherapy
34%
Carcinoma Cell
34%
Glioblastoma
34%
Uterine Cervix Carcinoma
34%
Prostate Cancer
34%
Biopsy
34%
Prostate Biopsy
34%
Human Papillomavirus Type 16
31%
Overall Survival
31%
Progression Free Survival
28%
Hazard Ratio
22%
Protein P53
18%
Biological Marker
17%
Somatics
17%
DNA Damage
13%
Cell Cycle Arrest
12%
Infection
12%
Whole Genome Sequencing
11%
Cell Death
10%
Retinoblastoma
8%
Human Papillomavirus Type 18
8%
Radiosensitivity
8%
Antiinfective Agent
6%
Cancer Treatment
6%
DNA Repair
6%
Tumor Cell
6%
Disease Predisposition
6%
Hypersensitivity
6%
Cancer Therapy
6%
Retrospective Cohort Study
6%
Odds Ratio
6%
Prognostic Factor
5%
Viral Transcription
5%
Chromosome 7
5%
Pancreatic Cancer Cell Line
5%
Base
5%
